Intercept Pharmaceuticals

Intercept-Logo.jpg

Intercept and the associated logos are trademarks of Intercept Pharmaceuticals, Inc.

We’re excited to be joining wotj Intercept for the TRUTH About NASH roundtable discussion in Washington, DC. We’ve assembled a dynamic group of people who all touch this disease in diverse ways, and look forward to a robust conversation encompassing varying viewpoints. As NASH progresses to becoming the leading indication for liver transplants in the U.S., we believe cross-stakeholder discussions like this are imperative – not only to help identify barriers to care and gaps in knowledge, but also to begin to pave the road to potential solutions for this community. 

We will be reviewing the findings from a new survey that takes a 360º look at NASH from the perspectives of healthcare professionals, diagnosed patients and the American public. We believe the survey will provide great stimuli for a discussion of some of the challenges facing people living with NASH.

This effort is part of our program to expand the discussion of liver disease and seek better solutions for patients and those who are asymptomatic but at risk.

Showing 2 reactions

Please check your e-mail for a link to activate your account.

Click for our online community

connect